Cargando…

Visceral leishmaniasis cyclical trends in Bihar, India – implications for the elimination programme.

Background: Visceral leishmaniasis (VL) is a vector-borne disease of public health importance in India, with the highest burden of disease in the states of Bihar, Jharkhand, West Bengal and Uttar Pradesh. The disease is currently targeted for elimination (annual incidence to less than one per 10,000...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deb, Rinki M, Stanton, Michelle C, Foster, Geraldine M, Das Gupta, Rudra K, Roy, Nupur, Das, Pradeep, Dhariwal, Akshay C, Coleman, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000 Research Limited 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6139379/ https://www.ncbi.nlm.nih.gov/pubmed/30234191 http://dx.doi.org/10.12688/gatesopenres.12793.1

Ejemplares similares

Adaptation of a malaria surveillance system for use in a visceral leishmaniasis elimination programme
por: Foster, Geraldine M., et al.
Publicado: (2017)

Visceral Leishmaniasis in Rural Bihar, India
por: Hasker, Epco, et al.
Publicado: (2012)

Knockdown resistance mutations predict DDT resistance and pyrethroid tolerance in the visceral leishmaniasis vector Phlebotomus argentipes
por: Gomes, Bruno, et al.
Publicado: (2017)

Understanding the transmission dynamics of Leishmania donovani to provide robust evidence for interventions to eliminate visceral leishmaniasis in Bihar, India
por: Cameron, Mary M., et al.
Publicado: (2016)

Impact of ASHA Training on Active Case Detection of Visceral Leishmaniasis in Bihar, India
por: Das, Vidya Nand Ravi, et al.
Publicado: (2014)

Impact of IRS: Four-years of entomological surveillance of the Indian Visceral Leishmaniases elimination programme
por: Deb, Rinki, et al.
Publicado: (2021)

Visceral Leishmaniasis in Muzaffarpur District, Bihar, India from 1990 to 2008
por: Malaviya, Paritosh, et al.
Publicado: (2011)

Mathematical modelling of the use of insecticide-treated nets for elimination of visceral leishmaniasis in Bihar, India
por: Fortunato, Anna K., et al.
Publicado: (2021)

TLR4 and TLR9 polymorphism: Probable role in susceptibility among the population of Bihar for Indian visceral leishmaniasis
por: Mandal, Abhishek, et al.
Publicado: (2021)

Molecular surveillance of insecticide resistance in Phlebotomus argentipes targeted by indoor residual spraying for visceral leishmaniasis elimination in India
por: Reid, Emma, et al.
Publicado: (2023)

Longitudinal Study of Transmission in Households with Visceral Leishmaniasis, Asymptomatic Infections and PKDL in Highly Endemic Villages in Bihar, India
por: Das, Vidya Nand Ravi, et al.
Publicado: (2016)

Eliminating visceral leishmaniasis in South Asia: the road ahead
por: Rijal, Suman, et al.
Publicado: (2019)

Impact of intensified control on visceral leishmaniasis in a highly-endemic district of Bihar, India: an interrupted time series analysis
por: Kumar, Vijay, et al.
Publicado: (2022)

Variations in visceral leishmaniasis burden, mortality and the pathway to care within Bihar, India
por: Jervis, Sarah, et al.
Publicado: (2017)

Diagnosis of Visceral Leishmaniasis in Bihar India: Comparison of the rK39 Rapid Diagnostic Test on Whole Blood Versus Serum
por: Matlashewski, Greg, et al.
Publicado: (2013)

Visceral Leishmaniasis Elimination Programme in India, Bangladesh, and Nepal: Reshaping the Case Finding/Case Management Strategy
por: Mondal, Dinesh, et al.
Publicado: (2009)

Long-term incidence of relapse and post-kala-azar dermal leishmaniasis after three different visceral leishmaniasis treatment regimens in Bihar, India
por: Goyal, Vishal, et al.
Publicado: (2020)

Trends in spatio-temporal dynamics of visceral leishmaniasis cases in a highly-endemic focus of Bihar, India: an investigation based on GIS tools
por: Mandal, Rakesh, et al.
Publicado: (2018)

Visceral leishmaniasis outbreaks in Bihar: community-level investigations in the context of elimination of kala-azar as a public health problem
por: Priyamvada, Khushbu, et al.
Publicado: (2021)

Post Kala-Azar Dermal Leishmaniasis following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) for Primary Visceral Leishmaniasis in Bihar, India
por: Burza, Sakib, et al.
Publicado: (2014)

Kala-azar elimination in a highly-endemic district of Bihar, India: A success story
por: Kumar, Vijay, et al.
Publicado: (2020)

Field safety and effectiveness of new visceral leishmaniasis treatment regimens within public health facilities in Bihar, India
por: Goyal, Vishal, et al.
Publicado: (2018)

Challenges of using modelling evidence in the visceral leishmaniasis elimination programme in India
por: Dial, Natalie J., et al.
Publicado: (2022)

Costs and outcomes of active and passive case detection for visceral leishmaniasis (Kala-Azar) to inform elimination strategies in Bihar, India
por: Dial, Natalie J., et al.
Publicado: (2021)

Visceral leishmaniasis: Spatiotemporal heterogeneity and drivers underlying the hotspots in Muzaffarpur, Bihar, India
por: Bulstra, Caroline A., et al.
Publicado: (2018)

India can consider integration of three eliminable disease control programmes on malaria, lymphatic filariasis, and visceral leishmaniasis
por: Rahi, Manju, et al.
Publicado: (2021)

Field effectiveness of new visceral leishmaniasis regimens after 1 year following treatment within public health facilities in Bihar, India
por: Goyal, Vishal, et al.
Publicado: (2019)

Risk Factors for Visceral Leishmaniasis Relapse in Immunocompetent Patients following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) in Bihar, India
por: Burza, Sakib, et al.
Publicado: (2014)

Five-Year Field Results and Long-Term Effectiveness of 20 mg/kg Liposomal Amphotericin B (Ambisome) for Visceral Leishmaniasis in Bihar, India
por: Burza, Sakib, et al.
Publicado: (2014)

Correction: India can consider integration of three eliminable disease control programmes on malaria, lymphatic filariasis, and visceral leishmaniasis
por: Rahi, Manju, et al.
Publicado: (2022)

Towards elimination of visceral leishmaniasis in the Indian subcontinent—Translating research to practice to public health
por: Hirve, Siddhivinayak, et al.
Publicado: (2017)

Visceral Leishmaniasis and HIV Co-infection in Bihar, India: Long-term Effectiveness and Treatment Outcomes with Liposomal Amphotericin B (AmBisome)
por: Burza, Sakib, et al.
Publicado: (2014)

Innovations for the elimination and control of visceral leishmaniasis
por: Selvapandiyan, Angamuthu, et al.
Publicado: (2019)

A controlled, randomized nonblinded clinical trial to assess the efficacy of amphotericin B deoxycholate as compared to pentamidine for the treatment of antimony unresponsive visceral leishmaniasis cases in Bihar, India
por: Das, Vidya Nand Rabi, et al.
Publicado: (2009)

Pharmacotherapeutic Options for Visceral Leishmaniasis—Current Scenario
por: Pandey, Krishna, et al.
Publicado: (2009)

Genetically Modified Organisms and Visceral Leishmaniasis
por: Chhajer, Rudra, et al.
Publicado: (2014)

Developments in Diagnosis of Visceral Leishmaniasis in the Elimination Era
por: Singh, Om Prakash, et al.
Publicado: (2015)

Treatment of Visceral Leishmaniasis: Model-Based Analyses on the Spread of Antimony-Resistant L. donovani in Bihar, India
por: Stauch, Anette, et al.
Publicado: (2012)

Association of Interleukin-18 Gene Polymorphism with Susceptibility to Visceral Leishmaniasis in Endemic Area of Bihar, an Indian Population
por: Kumar, Dinesh, et al.
Publicado: (2014)

Visceral Leishmaniasis-HIV Coinfection as a Predictor of Increased Leishmania Transmission at the Village Level in Bihar, India
por: Cloots, Kristien, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cq07euj1vsfdj1624pi802faq1